Literature DB >> 7031128

Antigenicity in hamsters of inactivated vaccines prepared from recombinant influenza viruses.

M Hamzawi, R Jennings, C W Potter.   

Abstract

Inactivated vaccines prepared form influenza virus strains obtained by the recombination of A/PR/8/34 (H1N1) or A/FM/1/47 (H1N1) viruses with A/Victoria/3/75 (H3N2) virus, were tested for their antigenicity in hamsters. The parental origin of the genes of each cloned recombinant virus was determined by polyacrylamide gel electrophoresis, and vaccines prepared from each strain by concentration, purification on sucrose density gradients and inactivation with formalin. All the recombinant strains used in these studies possessed surface haemagglutinin and neuraminidase antigens derived from the A/Victoria/75 parent strain. On inoculation into hamsters, at equivalent concentrations, these vaccines varied in their ability to induce haemagglutination-inhibiting (HI) antibodies in the serum. This variation was not dependent on concentration and was observed using neutralization and single radial haemolysis, as well as HI. The possible reasons for the findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7031128      PMCID: PMC2134137          DOI: 10.1017/s0022172400069709

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  33 in total

1.  ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.

Authors:  C B LAURELL
Journal:  Anal Biochem       Date:  1965-02       Impact factor: 3.365

2.  Effect of preinfection and preimmunization on the serum antibody response to subsequent immunization with heterotypic influenza vaccines.

Authors:  R Jennings; C W Potter; C McLaren
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

3.  Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.

Authors:  M Aymard-Henry; M T Coleman; W R Dowdle; W G Laver; G C Schild; R G Webster
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

Review 4.  The regulatory role of macrophages in antigenic stimulation.

Authors:  E R Unanue
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

5.  Enhanced response to influenza A vaccines in hamsters primed by prior heterotype influenza infection.

Authors:  R Jennings; C W Potter
Journal:  Arch Gesamte Virusforsch       Date:  1973

6.  Segregation of antigenic and biological characteristics during influenza virus recombination.

Authors:  D McCahon; G C Schild
Journal:  J Gen Virol       Date:  1972-04       Impact factor: 3.891

7.  Correlated studies of a recombinant influenza-virus vaccine. II. Definition of antigenicity in experimental animals.

Authors:  J L Schulman; E D Kilbourne
Journal:  J Infect Dis       Date:  1971-11       Impact factor: 5.226

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Crystalline antigen from the influenza virus envelope.

Authors:  C M Brand; J J Skehel
Journal:  Nat New Biol       Date:  1972-08-02

10.  Influenza virus subunit vaccines: immunogenicity and lack of toxicity for rabbits of ether- and detergent-disrupted virus.

Authors:  R G Webster; W G Laver
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

View more
  3 in total

1.  Use of single radial haemolysis for assessing antibody response to influenza virus vaccines in animals.

Authors:  T L Smith; R Jennings; C W Potter
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

2.  Morphology and antigenicity studies on reassortant influenza (H3N2) viruses for use in inactivated vaccines.

Authors:  R M Pemberton; R Jennings; T L Smith
Journal:  J Hyg (Lond)       Date:  1985-04

3.  Reassortants of influenza B viruses for use in vaccines: an evaluation.

Authors:  A C Goodeve; R Jennings; C W Potter
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.